Descripción

In vitro and in vivo assessment data for metabolic drug interaction potential of dutasteride, characterizing cytochrome P450 enzyme inhibition and pharmacokinetic parameters.

Figure 8

Chart

Source Paper

In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole.

Pharmaceutics (2019)

PMID: 31835695

DOI: 10.3390/pharmaceutics11120673

Cite This Figure

![Figure 8: In vitro and in vivo assessment data for metabolic drug interaction potential of dutasteride, characterizing cytochrome P450 enzyme inhibition and pharmacokinetic parameters.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956158/bin/pharmaceutics-11-00673-g008.jpg)

> Source: Seong-Wook Seo et al. "In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutas." *Pharmaceutics*, 2019. PMID: [31835695](https://pubmed.ncbi.nlm.nih.gov/31835695/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956158/bin/pharmaceutics-11-00673-g008.jpg" alt="In vitro and in vivo assessment data for metabolic drug interaction potential of dutasteride, characterizing cytochrome P450 enzyme inhibition and pharmacokinetic parameters." />
  <figcaption>Figure 8. In vitro and in vivo assessment data for metabolic drug interaction potential of dutasteride, characterizing cytochrome P450 enzyme inhibition and pharmacokinetic parameters.<br>  Source: Seong-Wook Seo et al. "In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutas." <em>Pharmaceutics</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31835695/">31835695</a></figcaption>
</figure>

Evidencia relacionada

Ketoconazole para Alopecia Androgenética

Calificación A · 19 estudios

Dutasteride para Alopecia Androgenética

Calificación A · 99 estudios